- Home
- MNPR vs LPSN Comparison
MNPR vs LPSN Comparison
Compare MNPR & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- LPSN
- Stock Information
- Founded
- MNPR 2014
- LPSN 1995
- Country
- MNPR United States
- LPSN United States
- Employees
- MNPR 12
- LPSN N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- LPSN EDP Services
- Sector
- MNPR Health Care
- LPSN Technology
- Exchange
- MNPR Nasdaq
- LPSN Nasdaq
- Market Cap
- MNPR 292.9M
- LPSN 122.6M
- IPO Year
- MNPR 2019
- LPSN 2000
- Fundamental
- Price
- MNPR $48.50
- LPSN $1.38
- Analyst Decision
- MNPR Strong Buy
- LPSN Hold
- Analyst Count
- MNPR 4
- LPSN 6
- Target Price
- MNPR $43.00
- LPSN $1.18
- AVG Volume (30 Days)
- MNPR 67.7K
- LPSN 4.4M
- Earning Date
- MNPR 03-27-2025
- LPSN 02-26-2025
- Dividend Yield
- MNPR N/A
- LPSN N/A
- EPS Growth
- MNPR N/A
- LPSN N/A
- EPS
- MNPR N/A
- LPSN N/A
- Revenue
- MNPR N/A
- LPSN $334,736,000.00
- Revenue This Year
- MNPR N/A
- LPSN N/A
- Revenue Next Year
- MNPR N/A
- LPSN N/A
- P/E Ratio
- MNPR N/A
- LPSN N/A
- Revenue Growth
- MNPR N/A
- LPSN N/A
- 52 Week Low
- MNPR $1.55
- LPSN $0.45
- 52 Week High
- MNPR $49.98
- LPSN $2.84
- Technical
- Relative Strength Index (RSI)
- MNPR 66.31
- LPSN 54.91
- Support Level
- MNPR $34.41
- LPSN $1.29
- Resistance Level
- MNPR $44.86
- LPSN $1.57
- Average True Range (ATR)
- MNPR 5.69
- LPSN 0.13
- MACD
- MNPR 1.13
- LPSN -0.01
- Stochastic Oscillator
- MNPR 91.91
- LPSN 47.22
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.